Spots Global Cancer Trial Database for hpn328
Every month we try and update this database with for hpn328 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study in Patients With Advanced Cancers Associated With Expression of DLL3 | NCT04471727 | Small-Cell Lung... Neuroendocrine ... | HPN328 Atezolizumab | 18 Years - 100 Years | Harpoon Therapeutics | |
Study in Patients With Advanced Cancers Associated With Expression of DLL3 | NCT04471727 | Small-Cell Lung... Neuroendocrine ... | HPN328 Atezolizumab | 18 Years - 100 Years | Harpoon Therapeutics |